SCHEDULE 13G/A: Adage Capital Management Amends Passive Stake in Compass Therapeutics, Holding 4.36% of Common Stock
Beneficial Ownership Amendment
Adage Capital Management, L.P. and its principals, Robert Atchinson and Phillip Gross, have filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.36% in Compass Therapeutics, Inc. as of December 31, 2024.
Summary
- Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Compass Therapeutics, Inc.
- The filing indicates beneficial ownership of 5,994,810 shares of Compass Therapeutics, Inc. common stock.
- This represents 4.36% of the company's common stock outstanding.
- The percentage is calculated based on 137,589,171 shares outstanding as of November 8, 2024, as reported in the company's Quarterly Report for the quarter ended September 30, 2024, filed on November 12, 2024.
- The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- Adage Capital Partners GP, L.L.C. is noted as no longer being a beneficial owner of securities held by ACP.
Sentiment
Score: 5
Explanation: Neutral. This is a factual disclosure of passive ownership, not a performance or strategic update.
Future Outlook
NA
Key Dates
| Date | Description |
|---|---|
| 2024-11-08 | Date as of which 137,589,171 shares of Common Stock were reported outstanding in the Company's Quarterly Report. |
| 2024-11-12 | Date of filing of the Company's Quarterly Report for the quarter ended September 30, 2024. |
| 2024-12-18 | Effective date for structured data requirements applicable to Schedule 13G filings. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end date). |
| 2025-02-12 | Date of filing of this Schedule 13G/A. |
Keywords
Compass Therapeutics, Adage Capital Management, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional investor, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.